William Williams

BriaCell Therapeutics Corp.

Image: William Williams

Joseph Wagner, Ph.D., President and CEO of BriaCell, has 15 years' experience in C-level positions in multiple biotech companies. He is the former and president and CEO of OncoCyte Corp., where he led development of three cancer diagnostic products that currently are in trials involving more than 2,000 patients. As president and CTO of Cell Targeting Inc., he was instrumental in its acquisition by BioTime Inc. He led the first allogeneic cell therapy program for heart disease as vice president of Neuronyx, in partnership with Johnson & Johnson. Throughout his career, he has raised more than $100M in capital in public, private and angel funding rounds, and more than $20M in nondilutive grant and collaborative funding.

Due to permission requirements, not all quotes are shown.